| 28.06.2022 07:00 | FARN | Announcement of Placing | RNS |
| 16.06.2022 12:00 | FARN | Faron notice of EGM | RNS |
| 15.06.2022 19:24 | FARN | IN BRIEF: Faron Pharma reveals topline results from MATINS trial | Alliance |
| 15.06.2022 07:00 | FARN | Faron Announces Top-Line 12-Month Survival Results | RNS |
| 08.06.2022 16:54 | FARN | IN BRIEF: Faron Pharma doses first patient in bexmarilimab study | Alliance |
| 08.06.2022 07:00 | FARN | First Patient Dosed in Ph I/II BEXMAB Combo Study | Reach |
| 01.06.2022 07:00 | FARN | Exercise of options | RNS |
| 30.05.2022 07:00 | FARN | Presentation of Biomarker Analysis at ASCO | Reach |
| 16.05.2022 17:35 | FARN | IN BRIEF: US and Finland approve Faron's bexmarilimab study | Alliance |
| 16.05.2022 07:00 | FARN | FDA and FIMEA approve BEXMAB study to begin | RNS |
| 12.05.2022 19:45 | MTW, CMET, HEIQ | TRADING UPDATES: Belluscura to raise GBP5 million; React buys | Alliance |
| 12.05.2022 15:50 | FARN | Ex Vivo Data Presented at EHA2022 Congress | Reach |
| 09.05.2022 07:00 | FARN | Mol Cancer Ther Publishes Bexmarilimab Research | Reach |
| 04.05.2022 11:15 | FARN | Grant of options | RNS |
| 22.04.2022 13:01 | FARN | Board Changes | RNS |
| 22.04.2022 13:00 | FARN | Results of AGM | RNS |
| 21.04.2022 16:30 | FARN | Faron Presents Melanoma Data at EADO | Reach |
| 08.04.2022 19:30 | FARN | IN BRIEF: Faron Pharmaceuticals CEO buys shares worth EUR71,000 | Alliance |
| 08.04.2022 15:45 | FARN | Managers’ Transactions | RNS |
| 05.04.2022 20:45 | PRIM, CASP, ADVT | TRADING UPDATES: Rambler ups production; SRT Marine anticipates loss | Alliance |
| 05.04.2022 07:00 | FARN | Faron Closes HIBISCUS Trial | RNS |
| 25.03.2022 13:21 | SOHO, PMG, UKOG | EARNINGS UPDATES: Everyman revenue doubles; Aeorema in interim profit | Alliance |
| 25.03.2022 09:00 | FARN | Notice of Faron Pharmaceuticals Ltd’s AGM | RNS |
| 25.03.2022 07:15 | FARN | Faron´s Annual Report 2021 Published | RNS |
| 25.03.2022 07:00 | FARN | Financial Statement January 1 to December 31 2021 | RNS |
| 18.03.2022 16:09 | WIX, SMIN, FARN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 14.03.2022 14:14 | FARN | IN BRIEF: Faron research sheds light on Covid-linked mutations | Alliance |
| 14.03.2022 07:00 | FARN | Faron Publishes Research From INTEREST Trial | Reach |
| 09.03.2022 07:00 | FARN | Presentation of Biomarker Data at AACR 2022 | Reach |
| 07.03.2022 07:00 | FARN | Notice of 2021 Full-Year Results and Annual Report | Reach |
| 04.03.2022 20:53 | AGY, SEED, ONC | TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal | Alliance |
| 04.03.2022 07:00 | FARN | Faron presents at upcoming conferences | Reach |
| 28.02.2022 17:45 | FARN | Faron Board Issues Warrants to IPF Partners | RNS |
| 28.02.2022 07:00 | FARN | Faron Obtains Debt Funding from IPF Partners | RNS |
| 23.02.2022 20:11 | AVON, AMC, CZN | TRADING UPDATES: BiVictriX expands development; Okyo wins US patent | Alliance |
| 23.02.2022 07:00 | FARN | Faron Updates on Bexmarilimab Development Program | RNS |
| 14.02.2022 07:00 | FARN | Faron Announces R&D Day | RNS |
| 03.02.2022 10:40 | FARN | Scientific Reports Publishes INFORAAA Results | RNS |
| 31.01.2022 13:30 | FARN | Holdings in Company | RNS |
| 31.01.2022 07:00 | FARN | Juho Jalkanen Appointed Chief Operating Officer | RNS |
| 28.01.2022 07:00 | FARN | Grant of options | RNS |
| 24.01.2022 07:00 | FARN | Faron at Proactive One2One Investor Forum | Reach |
| 17.01.2022 07:00 | FARN | Faron to Present at Redeye Fight Cancer Seminar | Reach |
| 05.01.2022 07:00 | FARN | Faron to Present at H.C. Wainwright BioConnect | Reach |
| 04.01.2022 07:00 | FARN | Faron Appoints Marie-Louise Fjällskog as CMO | RNS |
| 21.12.2021 07:00 | FARN | Faron’s financial calendar for 2022 | RNS |
| 09.12.2021 07:00 | FARN | Faron Announces Topline MATINS Biomarker Analysis | RNS |
| 01.12.2021 07:00 | FARN | Change in Faron’s Management Team | RNS |
| 16.11.2021 07:00 | FARN | Faron to Present at Jefferies Conference 2021 | Reach |
| 09.11.2021 07:00 | FARN | Faron awarded EUR 3.8 Million in Arbitration Case | RNS |
| 03.11.2021 15:55 | FARN | Cellular and Molecular Life Sciences Publication | Reach |
| 07.10.2021 07:00 | FARN | Exercise of options | RNS |
| 05.10.2021 11:30 | FARN | Holding(s) in Company | RNS |
| 01.10.2021 14:00 | FARN | Registration of Placing Shares with Trade Register | RNS |
| 01.10.2021 07:00 | FARN | Results of Placing and Issue Price | RNS |
| 30.09.2021 16:31 | FARN | Proposed Issue and Placing of Shares | RNS |
| 17.09.2021 07:00 | FARN | Presentation of Updated MATINS Data at ESMO | RNS |
| 09.09.2021 07:00 | FARN | Faron Announces Presentation at ESMO Congress | Reach |
| 07.09.2021 07:00 | FARN | Faron to Present at H.C. Wainwright Conference | Reach |
| 26.08.2021 07:00 | FARN | Half-Year Financials, January 1 – June 30 2021 | RNS |
| 25.08.2021 07:00 | FARN | First Patient Dosed in Phase II/III COVID-19 Trial | RNS |
| 28.07.2021 07:00 | FARN | Notice of Half-Year Report | RNS |
| 12.07.2021 07:00 | FARN | Faron to Host KOL Webinar on Clever-1 Receptor | Reach |
| 22.06.2021 07:00 | FARN | Updated corporate presentation | RNS |
| 14.06.2021 11:05 | FARN | Second Price Monitoring Extn | RNS |
| 14.06.2021 11:00 | FARN | Price Monitoring Extension | RNS |
| 14.06.2021 07:00 | FARN | Bexmarilimab granted key US patent | RNS |
| 03.06.2021 07:00 | FARN | Bexmarilimab results published in CCR | RNS |
| 17.05.2021 07:00 | FARN | Bexmarilimab shows promising anti-tumour activity | RNS |
| 14.05.2021 07:00 | FARN | US rights to patent related to Traumakine | RNS |
| 10.05.2021 14:30 | FARN | Holding(s) in Company | RNS |
| 29.04.2021 12:45 | FARN | Grant of options | RNS |
| 23.04.2021 13:45 | FARN | Result of AGM | RNS |
| 23.04.2021 13:45 | FARN | Board Change | RNS |
| 29.03.2021 07:00 | FARN | Appointment of a Broker | RNS |
